AV
Amgen Ventures
Venture CapitalActiveAmgen Ventures is a California-based investment firm focused on early- and late-stage biotechnology companies.
San Francisco, United StatesFounded 1996
84
Investments
4
Exits
—
AUM
4.8%
Exit Rate
Get contact info, warm intros & fit scores
Sign up to unlock emails, Signal intro paths, and personalized fit analysis for Amgen Ventures.
Investment Thesis & Strategy
Amgen Ventures invests in early- and late-stage biotechnology companies, leveraging its expertise in the biotech industry to support innovative ventures.
Investment Activity
Deals per year over the last 7 years
1
20160
20171
20184
20192
20203
20211
2022Portfolio Companies
Selected investments from their portfolio of 84 companies
R
Rgenta Therapeutics
Biotech · Series A, 2022
V
Ventyx Biosciences
Biotech · Series A, 2021
T
Tessera Therapeutics
Biotech · Series A, 2021
M
MB2
Biotech · Series A, 2021
L
Lycia Therapeutics
Biotech · Series A, 2020
G
Generate Biomedicines
Biotech · Series A, 2020
X
Xilio Therapeutics
Biotech · Series A, 2019
V
Valo Health
Biotech · Series A, 2019
S
Sana Biotechnology
Biotech · Series A, 2019
V
Verve Therapeutics
Biotech · Series A, 2019
C
Cerevel Therapeutics
Biotech · Series A, 2018
N
NextCure
Biotech · Series A, 2016
Notable Exits
CompanyTypeYearValue / Acquirer
ChemoCentryxAcquisition2022$4B
Five Prime TherapeuticsAcquisition2021$1.9B
Portola PharmaceuticalsAcquisition2020$1.4B
ARMO BioSciencesAcquisition2018$1.6B
Frequently Asked Questions
Amgen Ventures focuses on Series A, Series B, Series C+ stage investments.
Related Investors
Index Ventures
San Francisco, United States · 827 deals
First Round Capital
San Francisco, United States · 742 deals
Benchmark
San Francisco, United States · 600 deals
Founders Fund
San Francisco, United States · 564 deals
Matrix Partners
San Francisco, United States · 549 deals
Bain Capital Ventures
San Francisco, United States · 438 deals